Alpha10X Emerges From Stealth With $9.4 Million In Seed Funding And Expands Leadership Team To Bring Artificial Intelligence To Life Sciences Investment

Life science is a vast, entangled system that blurs the lines between the physical, digital, and biological. Public policymakers, investors across asset classes, and business leaders, lack the data-driven decision-support systems needed to decode the complexity, to predict the future, and target their programs and capital at the innovations that may deliver maximum impact and ROI. The ALPHA10X platform applies state-of-the-art artificial intelligence models and methods to shape precise investment knowledge from billions of data entities and their connections, generating actionable insights, and predicting the future with high accuracy. The AI is designed to seek "Alpha," to beat the expected market return, for all in the value chain, investors, acquirers, and founders.